Group D Retinoblastoma
Oncology
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Group D Retinoblastoma?
There are 1 clinical trial targeting Group D Retinoblastoma tracked by BioSniper.
What is the prevalence of Group D Retinoblastoma?
The estimated prevalence of Group D Retinoblastoma is approximately 0.1 per 100,000 population.
Deep-dive into Group D Retinoblastoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis